Effect of High Body Mass Index on the Prognosis of Diffuse Large B-Cell Lymphoma
Yukako Hattori(Kanagawa Prefectural Hospital Organization), Yoshiaki Ishigatsubo(Yokohama City University), Kazuho Miyashita(Fujisawa City Hospital), Hirotaka Takasaki(Kanagawa Prefectural Hospital Organization), Shin Fujisawa(Yokohama City University Medical Center), Naoto Tomita(St. Marianna University School of Medicine), Hiroyuki Takahashi(Yokohama City University), Yasufumi Ishiyama(Kanagawa Prefectural Hospital Organization), Rika Kawasaki(Yokohama City University Medical Center), Kenji Motohashi(Yokohama City University Medical Center), Katsumichi Fujimaki(Fujisawa City Hospital), Kumiko Kishimoto(Hiratsuka City Hospital), Satoshi Koyama(Yokohama City University), Yuki Nakajima(Fujisawa City Hospital), Rika Sakai(Yokohama City University Medical Center), Chizuko Hashimoto(Yamato Municipal Hospital), Shigeki Motomura(Kanagawa Prefectural Hospital Organization), Taisei Suzuki(Hiratsuka City Hospital)
Cited by 0
Related Papers
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149
Nucleosides and nucleotides. 100. 2'-C-Cyano-2'-deoxy-1-.beta.-D-arabinofuranosylcytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside
|Journal of Medicinal Chemistry|1991|85
Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.
|PubMed|1994|81
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era
|European Journal Of Haematology|2013|58